Abstract
Neutralizing antibodies in the subjects of an inactivated SARS-CoV-2 vaccine clinical trial showed a decreasing trend over months. An investigation studying the third immunization suggested that the waning of neutralizing antibodies in individuals administered two doses of inactivated vaccine does not mean the disappearance of immunity.
Keywords:
COVID-19; SARS-CoV-2; antibody waning; immune memory; inactivated vaccine.
MeSH terms
-
Adolescent
-
Adult
-
Antibodies, Neutralizing / immunology
-
Antibodies, Viral / immunology*
-
COVID-19 / prevention & control*
-
COVID-19 Vaccines / administration & dosage
-
COVID-19 Vaccines / immunology*
-
Humans
-
Immunization, Secondary*
-
Immunologic Memory*
-
Middle Aged
-
Vaccination / statistics & numerical data
-
Vaccines, Inactivated / administration & dosage
-
Vaccines, Inactivated / immunology
-
Young Adult
Substances
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
COVID-19 Vaccines
-
Vaccines, Inactivated
Grants and funding
This work was supported by Applied Basic Research Key Project of Yunnan: [Grant Number 202003AC100003,202003AC100009]; The National Key Research and Development Program of China: [Grant Number 2020YFC0849700,2020YFC0860600]; the Program of Chinese Academy of Medicine Science: [Grant Number 2020-I2M-2-014,2020HY320001].